Johnson & Johnson's Tecvayli has been approved as part of a combination regimen with its Genmab-partnered Darzalex Faspro as a second-line therapy for relapsed or refractory multiple myeloma, just 55 ...

AND MAYOR CANTRELL IS SPEAKING OUT IN THE LAST HALF HOUR, AND SHE’S ASKING THE COMMUNITY TO STAND TOGETHER IN PRAYER. IN A STATEMENT, SHE SAYS, QUOTE, WE MUST REMAIN VIGILANT IN OUR SUPPORT OF THE NEW ...